ESC 365 - Targeted medical treatment based on specific endotype defined by intracoronary physiology testing leads to rapid improvement of quality of life in symptomatic patients with INOCA

ESC2025 Premium Access

Targeted medical treatment based on specific endotype defined by intracoronary physiology testing leads to rapid improvement of quality of life in symptomatic patients with INOCA

Session: Chronic coronary syndromes: MINOCA/INOCA and non-significant coronary artery disease

Topic: Coronary Microcirculation and Collaterals

Speaker: Doctor B. Vitola (Riga, LV)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Barbara Vitola

Paul Stradins Clinical University Hospital, Riga (Latvia)

1 follower

6 more presentations in this session

Prognostic stratification by coronary flow reserve and left atrial volume index in patients with non-obstructive coronary artery disease

Speaker: Doctor A. Ito (Yokosuka, JP)

Utility of myocardial contrast echocardiography for evaluating microvascular dysfunction in patients with ischemia and non-obstructive coronary arteries

Speaker: Professor Y. Mu (Urumqi, CN)

MINOCA: frequency and clinical features in different LGE-patterns

Speaker: Doctor E. Tukhsanboev (Dushanbe, TJ)

Your heart speaks survey programme - a global survey on the ANOCA patient journey (diagnosis)

Speaker: Doctor S. La (Adelaide, AU)

Basal coronary microvascular resistance predicting death and heart failure in patients without functional coronary stenosis

Speaker: Doctor I. Saito (Yokosuka, JP)

Access the full session

Chronic coronary syndromes: MINOCA/INOCA and non-significant coronary artery disease

Speakers: Doctor B. Vitola, Doctor A. Ito, Professor Y. Mu, Doctor E. Tukhsanboev, Doctor S. La...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources